Medicinal Organic Cannabis Australia (MOCA) is a licensed and approved wholesaler with head offices in Australia, New Zealand and Italy. In Australia we supply our approved range of products to Hospitals, Pharmacies and Medical Practitioners.
Our product delivery times range from 2-4 weeks. We ship from our logistics facilities in Europe, the United Kingdom and the United States.
n.b. In Australia WE DO NOT sell our products directly to the public.
Choose from our range of organic products
MOCA CBD Isolate
Best Used For:
Edibles, oils, tinctures, creams, gels, capsules, sprays, topicals, salves, vapables.
MOCA CBD Isolate is a pure, crystalline powder that contains 99%+ pure CBD. CBD Isolate contains only CBD. All the plant matter contained in the hemp plant, including oils, waxes, chlorophyll and more are removed, resulting in an almost pure CBD molecule.
Our CBD Isolate is 99%+ pure so one gram of CBD Isolate will contain more that 990 milligrams of CBD. In other words, for each milligram of powder, you will have approximately one milligram of CBD. MOCA CBD Isolate makes it easy to measure precise amounts.
The Therapeutic Goods Administration (TGA) is the regulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia. It is a Division of the Australian Department of Health established under the Therapeutic Goods Act 1989
Our products are non-ARTG (unregistered) and available under the Special Access Scheme (SAS).All MOCA products are Australian made and conform with Therapeutic Goods (Standard for Medicinal Cannabis) (TGO 93) Order 2017
Our Vision - MOCA's vision is to produce organic cannabis medication which is affordable to everyone.
Mission Statement - To successfully supply approved businesses of all sizes with our high quality, ethically grown organic medical cannabis products.
Objective - MOCA’s primary objective is to become a leader in the Australian medical cannabis market. Our focus is on reducing patient access costs for medical cannabis products. We aim to educate medical practitioners, pharmacies and consumer markets on the health benefits of our products. The Company targets supplying the rapidly growing market in Australia and internationally with high quality organic cannabis medicine.
Our first responsibility is to the doctors, nurses, and patients, to mothers and fathers and all others who will use our products and services.
Secondly, we are responsible to our employees who work with us throughout the world.
Thirdly, we are responsible to the communities in which we live and work and to the world community at large.
Our final responsibility is to our shareholders.